Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathophysiology of Post Amputation Pain
NCT01632709Phase 4Completed
- Sponsor
- Shirley Ryan AbilityLab
- Start
- May 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in post-amputation pain (PAP) (4 arms), sponsored by Shirley Ryan AbilityLab. Primary endpoint: Change in Pain Rating at 1 hour. Started May 2012; status: completed.
02
Drugs
bupivacaine
03
Conditions
post-amputation pain (PAP)
Beyond the preview
Go deeper on NCT01632709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01632709.